February 01, 2019
BONESUPPORTTM and Lund University to present at Orthopaedic Research Society (ORS) 2019 Annual Meeting
Media
January 30, 2019
Q4 incl. Full Year Report 2018
January 29, 2019
Modus Therapeutics strengthens Board with two key appointments
January 29, 2019
Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, Austria
January 25, 2019
Nordic Nanovector – Private placement successfully completed
January 24, 2019
Nordic Nanovector ASA (OSE: NANO) nomination committee proposes new Chairman
January 24, 2019
Oncopeptides has completed a directed share issue of approximately SEK 546 million
January 17, 2019
Targovax granted European Patent for mutant-RAS neoantigen platform lead products
January 11, 2019
Actavis infringes Orexo’s long term Zubsolv® US patent ´330
January 07, 2019
Modus Therapeutics completes enrollment of randomized, placebo-controlled Phase II clinical trial evaluating sevuparin for management of Acute Vaso-Occlusive Crisis in SCD patients
